Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joth Jacobson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myelomaChoon-Kee Lee, Bart Barlogie, Nikhil Munshi, et al.
Clinical Lymphoma|July 3, 2003
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survivalMaurizio Zangari, Bart Barlogie, Raymond Thertulien, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Advances in biology and therapy of multiple myelomaSophie Barillé-Nion, Bart Barlogie, Régis Bataille, et al.
British Journal of Haematology|December 21, 2002
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy IIJohn Shaughnessy, Erming Tian, Jeffrey Sawyer, et al.
British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.
Experimental Hematology|January 25, 2003
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioningChoon Kee Lee, Ashraf Badros, Bart Barlogie, et al.
Blood|January 18, 2003
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expressionJohn Shaughnessy, Joth Jacobson, Jeff Sawyer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myelomaChoon-Kee Lee, Bart Barlogie, Nikhil Munshi, et al.
Clinical Lymphoma|July 3, 2003
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survivalMaurizio Zangari, Bart Barlogie, Raymond Thertulien, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Advances in biology and therapy of multiple myelomaSophie Barillé-Nion, Bart Barlogie, Régis Bataille, et al.
British Journal of Haematology|December 21, 2002
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy IIJohn Shaughnessy, Erming Tian, Jeffrey Sawyer, et al.
British Journal of Haematology|August 26, 2004
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationMaurizio Zangari, Bart Barlogie, Elias Anaissie, et al.
Experimental Hematology|January 25, 2003
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioningChoon Kee Lee, Ashraf Badros, Bart Barlogie, et al.
Blood|January 18, 2003
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expressionJohn Shaughnessy, Joth Jacobson, Jeff Sawyer, et al.
Pageof 2